|
03/04/2024
|
07:30
|
Suspension - MGC Pharmaceuticals Limited
|
RNS
|
|
02/04/2024
|
15:40
|
Change of name to Argent BioPharma Limited
|
RNS
|
|
28/03/2024
|
09:12
|
PDMR Notification
|
RNS
|
|
28/03/2024
|
09:07
|
Refinancing of Convertible Securities Agreement
|
RNS
|
|
18/03/2024
|
08:23
|
Results of General Meeting
|
RNS
|
|
29/02/2024
|
09:36
|
Half-year Report
|
RNS
|
|
19/02/2024
|
16:00
|
Update - Application for Admission to Trading
|
RNS
|
|
13/02/2024
|
10:00
|
Dispatch of General Meeting Documents
|
RNS
|
|
31/01/2024
|
07:30
|
December 2023 Quarter Activity Report
|
RNS
|
|
11/01/2024
|
09:54
|
Director/PDMR Shareholding
|
RNS
|
|
22/12/2023
|
09:09
|
Company Update & Placing to Raise US$500,000
|
RNS
|
|
01/12/2023
|
08:09
|
Corporate Update - Board and UK Adviser Changes
|
RNS
|
|
30/11/2023
|
09:08
|
Results of Shareholder’s Annual General Meeting
|
RNS
|
|
16/11/2023
|
13:51
|
Holding(s) in Company
|
RNS
|
|
13/11/2023
|
09:15
|
Holding(s) in Company
|
RNS
|
|
09/11/2023
|
10:47
|
Holding(s) in Company
|
RNS
|
|
08/11/2023
|
11:52
|
Holding(s) in Company
|
RNS
|
|
08/11/2023
|
10:00
|
Capital Consolidation and US$7.9m Placement
|
RNS
|
|
01/11/2023
|
11:30
|
Consolidation and New Fund Raising
|
RNS
|
|
01/11/2023
|
11:03
|
MGC Secures US$7.9 Million In Firm Commitments
|
RNS
|
|
31/10/2023
|
09:32
|
Dispatch of Annual General Meeting Documents
|
RNS
|
|
30/10/2023
|
07:16
|
September 2023 Quarter Activity Report
|
RNS
|
|
25/10/2023
|
15:16
|
Results of Shareholder’s General Meeting
|
RNS
|
|
09/10/2023
|
10:02
|
Date of AGM & Closing Date of Director Nominations
|
RNS
|
|
29/09/2023
|
10:40
|
Annual Report for the year ended 30 June 2023
|
RNS
|
|
26/09/2023
|
07:36
|
Letter From the Managing Director
|
RNS
|
|
26/09/2023
|
07:35
|
Dispatch of General Meeting Documents
|
RNS
|
|
12/09/2023
|
07:00
|
Holding(s) in Company
|
RNS
|
|
05/09/2023
|
12:34
|
Results of Shareholder’s General Meeting
|
RNS
|
|
01/09/2023
|
07:30
|
Change of registry address notification
|
RNS
|
|
31/08/2023
|
08:44
|
30 June 2023 Preliminary Financial Report
|
RNS
|
|
30/08/2023
|
08:30
|
Share Purchase Plan Closed
|
RNS
|
|
15/08/2023
|
07:29
|
SPP – Extension of Closing Date
|
RNS
|
|
14/08/2023
|
07:00
|
Positive Pre-clinical Trial Results on CimetrA®
|
RNS
|
|
04/08/2023
|
09:10
|
Dispatch of General Meeting Documents
|
RNS
|
|
03/08/2023
|
14:23
|
Australian Prospectus & Share Purchase Plan
|
RNS
|
|
02/08/2023
|
10:25
|
Application for Admission to Trading
|
RNS
|
|
01/08/2023
|
08:56
|
MGC Pharma Launches Share Purchase Plan
|
RNS
|
|
31/07/2023
|
07:00
|
Permission for first import of Psilocybin
|
RNS
|
|
28/07/2023
|
09:05
|
Resignation of Joint Company Secretary
|
RNS
|
|
28/07/2023
|
08:00
|
June 2023 Quarter Activity Report and Cash Flow
|
RNS
|
|
21/07/2023
|
10:56
|
Holding(s) in Company
|
RNS
|
|
18/07/2023
|
11:41
|
PDMR Notification
|
RNS
|
|
14/07/2023
|
07:00
|
£0.7 million Fundraising
|
RNS
|
|
12/07/2023
|
07:00
|
Further re AMC Places another $1M Order of ArtemiC
|
RNS
|
|
07/07/2023
|
07:00
|
AMC Places Another US$1M Order of ArtemiC™
|
RNS
|
|
03/07/2023
|
07:00
|
Reclassification of Psychedelic Compounds
|
RNS
|
|
30/06/2023
|
09:31
|
Details of Company Address
|
RNS
|
|
30/06/2023
|
09:30
|
Company Update
|
RNS
|
|
29/06/2023
|
10:22
|
Results of Shareholder’s General Meeting
|
RNS
|